$0.8735
0.44102.57%
가까이에: Aug 21, 5:00 PM EST
$0.8256
-0.0479-5.48%
시간외: Aug 21, 7:59 PM EST
Benzinga
Benzinga
Benzinga
일요일, 8월 23
Werewolf Therapeutics Inc
HOWLNASDAQ
인수합병: Ambros Therapeutics, Inc announced it will be merged with Werewolf Therapeutics (HOWL) on Friday, August 21, 2026 for $47.5M paid in stock
Werewolf Therapeutics Earnings & Forecasts
Werewolf Therapeutics (HOWL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Werewolf Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.31 | $-0.30 | $-0.34 | $-0.39 |
| Actual | $0.08 | $-0.28 | $-0.20 | $-0.36 |
| Surprise | +125.8% | +6.67% | +41.2% | +7.69% |
| Revenue | ||||
| Estimate | — | — | $600000 | $600000 |
| Actual | $21.0M | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | -100.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.30 | $-0.23 |
| Revenue | ||
| Consensus | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved